|Question On Notice No. 628 asked in the Legislative Council on 17 March 2022 by Hon Martin Aldridge |
Question Directed to the: Minister for Medical Research
Parliament: 41 Session: 1
Tabled Paper No: 1285- View tabled paper
I refer to the Western
Australian Future Health Research and Innovation Fund, and I ask:
(a) from what date did the Minister for Medical
Research take responsibility for the Western Australian Future Health Research
and Innovation Fund Act 2012;
(b) by what instrument did responsibility transfer
from the Minister for Health to the Minister for Medical Research; and
(c) given the Government’s commitment and legislative amendment to prioritise COVID-19 research and innovation from the FHRI Account, will the Minister please detail the following since the establishment of the account:
(i) how much funding has been allocated to date to
(ii) how much funding has been expended to date from
(iii) please detail the projects and funding
recipients approved to date; and
(iv) of those identified in (iii), how many relate to
coronavirus research and innovation?
Answered on 10 May 2022
(a) 8 February 2022.
(b) The Western Australian Future Health Research and Innovation Fund Act 2012 was committed by the Governor to the Minister for Medical Research (except Part 3, which was committed to the Treasurer) under the Interpretation Act 1984 section 12(a) (Executive Council Minute 0044).
(c) (i) $33,900,000 allocated to the FHRI Account in 2020-21 and $32,400,000 allocated to the account in 2021-22. Total of $66,300,000 allocated to the account to date.
(ii) $22,311,089 expended from the FHRI Account to date. In addition, Programs and Initiatives with a combined total value of approximately $21 million are either at application review or procurement approval stages or are currently open to applications.
(iii) Projects and funding recipients approved to date detailed in tabled paper no. #. Funding approved to date is $40,778,231.
(iv) Of the projects and funding recipients approved to date, 18 projects relate to coronavirus research and innovation with an approved award value of $5,988,011.